• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Vaxart, Inc. - Common Stock (NQ:VXRT)

0.3200 UNCHANGED
Last Price Updated: 4:00 PM EDT, Jul 7, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Vaxart, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
3 Small-Cap Stocks With 158% to 329% Upside, According to Wall Street ↗
July 15, 2021
Analysts' high-water price targets imply some serious gains for these companies. 
Via The Motley Fool
Topics Economy
News headline image
Don’t Count on a Covid-19 Boost for Vaxart ↗
July 14, 2021
VXRT stock remains a speculative bet as the company's chance to develop an oral Covid-19 vaccine grows slimmer every day. 
Via InvestorPlace
News headline image
New Developments Have Made Vaxart Stock So Much More Attractive ↗
July 13, 2021
Vaxart recently made a licensing deal, and two research firms issued upbeat assessments of the company, making me more upbeat on VXRT stock. 
Via InvestorPlace
News headline image
Watch Out for a Selloff in Vaxart Stock ↗
July 09, 2021
VXRT stock's price may drop as their oral inoculation waits in the wings while other vaccine manufacturers take over the market. 
Via InvestorPlace
News headline image
Vaxart Inks Antiviral Asset Licensing Pact With Altesa Biosciences ↗
July 07, 2021
Vaxart Inc (NASDAQ: VXRT) has granted Altesa Biosciences Inc an exclusive worldwide license to develop and commercialize Vaxart's patented... 
Via Benzinga
Why Vaxart Shares Are Trading Higher Today ↗
June 11, 2021
Vaxart Inc (NASDAQ:VXRT) shares are trading higher by 30% ... 
Via Benzinga
News headline image
Vaxart Stock Could Make Another Big Return in the Future ↗
July 06, 2021
It might be tempting to dismiss VXRT stock now that other Covid-19 vaccines are available, but pill-based vaccines for diseases are appealing. 
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For June 30, 2021 ↗
June 30, 2021
Upgrades For Taiwan Semiconductor Manufacturing Co Ltd (NYSE: 
Via Benzinga
News headline image
Will the Promise of Avoiding the Needle Pay Off for Vaxart? ↗
June 28, 2021
VXRT stock just received a buy recommendation and a $13 price target from Jefferies, based on the promise of a oral vaccine instead of a needle. 
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For June 24, 2021 ↗
June 24, 2021
Upgrades Zelman upgraded the previous rating for Armstrong World Industries Inc (NYSE: 
Via Benzinga
News headline image
Is Now The Time To Buy Stock Or Options In Apple, PayPal, Square Or Vaxart? ↗
June 24, 2021
One of the most common questions traders have about stocks is “Why Is It Moving?” That’s why Benzinga created the Why I... 
Via Benzinga
News headline image
VXRT Stock: Can Redditors Help Vaxart Power Higher? ↗
June 18, 2021
Today, VXRT stock is climbing higher on an otherwise red day for the markets, as many speculate retail investors could be behind this rise. 
Via InvestorPlace
News headline image
Vaxart Is Still Not Worth Anywhere Near Its Present Price ↗
June 17, 2021
Vaxart is still not worth today's price. VXRT stock is worth no more than $6, especially if it's going to need another capital raise. 
Via InvestorPlace
News headline image
Why COVID Vaccine Stocks Dynavax, Novavax, and Vaxart Are Sinking Today ↗
June 15, 2021
The declines appear to be caused simply by volatility that's common with small biotech stocks. 
Via The Motley Fool
News headline image
Is It Too Late to Buy Vaxart Stock? ↗
June 15, 2021
The science looks fishy for this small-cap biotech. 
Via The Motley Fool
News headline image
Meme Stocks Continue To Surge As Traders Move To Biotech ↗
June 14, 2021
The meme stock crowd turned its attention to biotech and healthcare stocks, boosting some shares by as much as 10%. 
Via Talk Markets
News headline image
VXRT Stock: Why Redditors Are Betting on a Big Squeeze With Vaxart Today ↗
June 11, 2021
VXRT stock is on the move as the company received some very bullish coverage from an analyst initiating coverage today. 
Via InvestorPlace
News headline image
64 Biggest Movers From Friday ↗
June 14, 2021
Gainers Kanzhun Limited (NASDAQ: BZ) shares climbed 95.8% to close at $37.20 on Friday after the company priced its IPO at $19 per share. Novan, Inc. (NASDAQ: NOVN) shares gained... 
Via Benzinga
Topics Initial Public Offering
News headline image
Most Active Equity Options For Midday - Friday, June 11 ↗
June 11, 2021
Top tickers for midday: AMC, AAPL, TSLA, NIO, NVDA, AMZN, CLOV, SNAP, CLF, GME, PLTR, VXRT, AMD, MO, F, SENS, BAC, MSFT, BB, ET. 
Via Talk Markets
News headline image
Nasdaq, S&P 500 Eye Weekly Wins as Bond Yields Retreat ↗
June 11, 2021
The 10-year Treasury bond yield fell to a three-month low. 
Via Talk Markets
Topics Bonds Stocks
News headline image
46 Stocks Moving In Friday's Mid-Day Session ↗
June 11, 2021
Gainers Kanzhun Limited (NASDAQ: BZ) shares surged 77.4% to $33.70 after the company priced its IPO at $19 per share. Novan, Inc. (NASDAQ: NOVN) shares jumped 73.3% to $15.67... 
Via Benzinga
Topics Initial Public Offering
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
June 11, 2021
Gainers Novan (NASDAQ:NOVN) stock rose 71.04% to $15.46 during Friday's regular session. As of 12:30 EST, Novan's stock is trading at a volume of 109.3 million,... 
Via Benzinga
News headline image
Why Vaxart Stock Is Skyrocketing Today ↗
June 11, 2021
Investors are cheering an analyst's positive recommendation. 
Via The Motley Fool
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For June 11, 2021 ↗
June 11, 2021
Upgrades Barclays upgraded the previous rating for Ventas Inc (NYSE:VTR) from Equal-Weight to Overweight. In the first quarter, Ventas showed an EPS of $0.72, compared to... 
Via Benzinga
News headline image
Why Shares of Vaxart Plummeted 38.6% in May ↗
June 10, 2021
This isn't the first time its coronavirus vaccine pill has disappointed investors. 
Via The Motley Fool
News headline image
Bet on a No-Needle Vaccine Strategy with Vaxart ↗
June 09, 2021
Reimagining Covid-19 vaccines isn't an easy task, but Vaxart is prepared to innovate - and VXRT stock could move higher at any given moment. 
Via InvestorPlace
News headline image
10 More Current & Former Penny Stocks With High Short Interest ↗
June 08, 2021
High Short Interest Stocks Are Something Traders Are On The Hunt For & Here's Another 10 
Via Talk Markets
News headline image
28 Stocks Moving in Tuesday's Pre-Market Session ↗
June 08, 2021
Gainers Aytu Biopharma, Inc. (NASDAQ: AYTU) rose 37.8% to $7.40 in pre-market trading. Cyclerion Therapeutics, Inc. (NASDAQ: CYCN) rose 23.5% to $3.89 in pre-market trading... 
Via Benzinga
News headline image
5 High-Octane Growth Stocks With 54% to 94% Upside, According to Wall Street ↗
June 08, 2021
If analysts are correct, this assortment of rapidly growing companies could deliver big-time returns over the next year. 
Via The Motley Fool
Topics Economy
News headline image
These Vaccine Latecomers Could Still Win Big. Here's How ↗
June 07, 2021
The key is standing out from the crowd. 
Via The Motley Fool
Topics Cannabis
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap